News Focus
News Focus
icon url

NASDAQ2020

04/14/14 10:44 AM

#103305 RE: Couch #103217

5 STARS !!!!
icon url

YJ4LIFE

04/14/14 12:27 PM

#103361 RE: Couch #103217

Five stars Couch! Great DD as always.....thx ( limit 1 post per day )
icon url

Greenspam2

04/14/14 12:28 PM

#103362 RE: Couch #103217

Essential for all newbies: thanks Couch!!
icon url

no2koolaid

04/14/14 2:06 PM

#103394 RE: Couch #103217

Outstanding post. The various points show the alignment between the strategies employed by Elite, their internal capabilities and the opportunities inherent in the competitive environment. Business success cannot be determined by chart reading anymore than the road from Iowa to Denver foretells the terrain from Denver to Utah.
icon url

Je3232

04/16/14 7:26 AM

#103843 RE: Couch #103217

This is great summary. I'm not a Basher so please take this question in a positive way - with all that you wrote and all that's been said by the company, why does the stock trade at .34?

Markets usually get it right and there's some pretty smart people that trade this stuff (some). That said, how has no one taken notice and bought up this stock. Why haven't major analysts upgraded and covered this stock. Lots of great stuff should equal a better price that trades on the Nasdaq.

Thanks
icon url

Blaze2

09/09/14 7:48 AM

#125696 RE: Couch #103217

Good DD

Glade to still be invested here

$$ELTP$$

Blaze :)
icon url

Just give me $1.50

09/14/14 12:36 PM

#126785 RE: Couch #103217

LMAO.

"The answer is that Elite owns the IP rights to build a better Embeda that Actavis needs. Patented IP that Elite owns for 20 years."




icon url

Just give me $1.50

09/14/14 12:37 PM

#126786 RE: Couch #103217

Guess you didn't get the news about our patents.


5) Game Changing Intellectual Property (IP): (And why I am personally here!)

seekingalpha.com/instablog/4199131-couch/1941422-elite-pharmaceuticals-eltp-intellectual-property-ip-and-the-right-to-devise-a-better-pain-killer

Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally